Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Enanta Pharmaceuticals, Inc.
Enanta Pharmaceuticals, Inc.
ENTA
Valuace
70
Růst
53
Zdraví
55
Cena
$ 11.05
Dnes
--0.74 (-5.54%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.2B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-4
PS
4
Cena 1R
4-17
⌀ Cena
9.20
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
09-02-2026
Poslední dividenda

Profil

Enanta Pharmaceuticals, Inc., biotechnologická společnost, objevuje a vyvíjí malé molekuly léků pro léčbu virových infekcí a onemocnění jater. Mezi jeho výzkumné a vývojové cíle patří respirační syncytiální virus, SARS-CoV-2, lidský metapneumovirus a virus hepatitidy B. Společnost uzavřela s Abbott Laboratories společnou vývojovou a licenční smlouvu o identifikaci, vývoji a komercializaci HCV NS3 a NS3/4A proteázových inhibitorů, včetně paritapreviru a glekapreviru pro léčbu chronického viru hepatitidy C. Společnost Enanta Pharmaceuticals, Inc. byla založena v roce 1995 a sídlí ve Watertownu ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
131
Založení
2013-03-21
Adresa
500 Arsenal Street
CEO
Jay R. Luly
Web
www.enanta.com

Podobné společnosti

PRLD
Prelude Therapeutics Incorporated
$ 1.23
+ $ 0.04
TNYA
Tenaya Therapeutics, Inc.
$ 1.30
+ $ 0.02
FHTX
Foghorn Therapeutics Inc.
$ 4.53
+ $ 0.17
NAUT
Nautilus Biotechnology, Inc.
$ 1.63
+ $ 0.12
IMRX
Immuneering Corporation
$ 6.73
- $ 0.16
VYGR
Voyager Therapeutics, Inc.
$ 4.24
+ $ 0.01
AVIR
Atea Pharmaceuticals, Inc.
$ 3.29
+ $ 0.02

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues67.065.367.679.286.297.1122.5205.2206.6102.888.3160.947.732.141.741.922.8
Cost of Revenues0.04.60.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Gross Profit67.060.767.679.286.297.1122.5205.2206.6102.888.3160.947.732.141.741.922.8
Revenue 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Total Revenues18.615.118.314.917.014.618.017.118.018.9
Cost of Revenues0.00.00.00.00.00.00.00.00.00.7
Gross Profit18.615.118.314.917.014.618.017.118.018.3
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0163.5164.5174.1136.8142.294.957.540.523.218.716.815.111.59.7
Selling General & Admin Expenses0.00.00.052.945.532.527.426.223.420.717.013.510.06.25.35.06.1
Depreciation & Amortization4.95.12.32.42.93.33.63.32.52.11.70.60.40.20.20.50.6
Total Operating Expenses140.0146.1189.3216.4210.0206.6164.1168.5118.378.257.436.728.823.020.416.615.8
Operating Income-73.1-85.3-121.7-137.2-123.8-109.6-41.636.788.324.630.8124.119.09.021.325.36.9
Operating Income TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
R&D Expenses0.00.00.00.00.00.00.00.00.036.2
Selling General & Admin Expenses0.00.00.00.00.00.00.00.00.013.8
Depreciation & Amortization1.21.31.21.20.90.50.60.60.60.7
Total Operating Expenses29.933.537.239.540.544.542.249.852.950.0
Operating Income-11.3-18.4-18.9-24.5-23.5-29.9-24.2-32.8-34.9-31.0
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income9.19.514.811.41.62.06.50.00.02.51.71.00.50.20.10.10.0
Interest Expense8.87.710.95.11.60.00.08.84.90.00.00.00.00.00.03.20.0
Other Expense0.31.83.96.21.72.06.68.84.82.31.71.30.30.60.01.10.8
IBT-72.8-83.5-117.8-131.0-122.2-107.6-35.045.693.126.932.6125.519.39.621.423.37.7
Income Tax Expense-1.2-1.7-1.72.8-0.4-28.61.1-0.821.29.210.946.5-15.2-0.20.03.2-0.2
Net Income-71.5-81.9-116.0-133.8-121.8-79.0-36.246.472.017.721.779.034.49.621.423.37.9
Net Income TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Interest Income2.42.12.32.32.83.23.53.84.34.7
Interest Expense3.12.41.61.72.02.62.42.63.43.2
Other Expense-0.7-0.30.70.60.80.71.11.20.91.5
IBT-11.9-18.7-18.2-23.9-22.7-29.2-23.1-31.5-34.0-29.5
Income Tax Expense0.00.00.0-1.3-0.4-0.4-0.4-0.4-0.6-1.4
Net Income-11.9-18.7-18.3-22.6-22.3-28.8-22.7-31.2-33.4-28.1
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$-6.38$-5.91$-3.92$-1.81$2.37$3.74$0.93$1.14$4.23$1.88$-0.67$1.18$1.35$0.02
EPS Diluted$0.00$0.00$0.00$-6.38$-5.91$-3.92$-1.81$2.21$3.48$0.91$1.13$4.09$1.80$-0.67$0.52$0.59$0.02
Shares Outstanding21.421.321.221.020.620.219.919.619.319.118.918.718.49.81.21.212.7
Diluted Shares Outstanding21.421.321.221.020.620.219.921.020.719.419.219.319.29.82.62.614.1
Per Share Data TTM 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.33
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-1.33
Shares Outstanding21.421.421.321.421.221.221.221.221.121.1
Diluted Shares Outstanding21.421.421.321.421.221.221.221.221.121.1
Current Assets TTM 20242023202220212020201920182017201620152014201320122011
Cash And Equivalents36.437.285.444.057.287.151.263.965.716.621.730.78.910.56.8
Short Term Investments194.3211.0284.5205.2186.8299.5284.0244.8158.0193.5123.560.192.633.316.5
Total Cash & ST Investments230.7248.2369.9249.2244.0386.6335.2308.7223.7210.1145.290.8101.543.823.3
Accounts Receivable40.638.639.649.060.823.551.367.210.612.815.74.51.62.90.3
Inventory0.00.00.00.0-37.30.00.00.00.00.00.00.00.00.00.0
Other Current Assets15.313.013.313.451.426.715.34.53.59.29.712.71.60.61.5
Total Current Assets286.6299.9422.8311.7319.0436.8401.8380.4237.8232.2170.6108.0104.747.325.1
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents44.860.284.337.235.863.539.985.495.273.2
Short Term Investments159.3133.2132.3211.0194.3236.8297.2284.5291.4136.9
Total Cash & ST Investments204.1193.4216.7248.2230.1300.3337.2369.9386.6210.1
Accounts Receivable8.440.640.238.640.639.839.939.644.846.6
Inventory0.00.00.00.00.00.00.00.00.00.0
Other Current Assets10.28.911.313.015.910.913.213.317.114.5
Total Current Assets222.7242.9268.1299.9286.6351.0390.3422.8448.5271.1
Long-Term Assets TTM 20242023202220212020201920182017201620152014201320122011
Net Property, Plant & Equipment66.373.334.729.710.715.610.98.48.08.05.91.81.10.60.5
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Long-Term Investments45.93.40.029.3108.432.665.016.470.032.164.241.010.71.70.0
Other Long-Term Assets0.10.14.84.70.70.70.70.70.60.60.60.40.42.60.5
Total Long-Term Assets112.276.839.563.7119.849.388.033.888.849.175.447.412.34.91.0
Total Assets398.8376.7462.3375.4438.8486.1489.8414.2326.6281.3246.0155.4117.052.226.1
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment74.976.777.073.366.358.433.534.736.035.6
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets0.00.00.00.00.00.00.00.00.00.0
Long-Term Investments3.40.00.00.042.54.00.04.05.915.0
Other Long-Term Assets0.13.53.53.53.50.24.74.84.84.7
Total Long-Term Assets78.380.180.576.8112.262.538.239.546.755.3
Total Assets301.0323.0348.6376.7398.8413.6428.5462.3495.2326.4
Current Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Accounts Payable10.78.04.16.09.55.76.74.73.73.41.51.91.51.90.6
Short-Term Debt34.736.05.32.94.24.30.00.00.10.10.10.00.00.00.0
Other Current Liabilities12.813.553.420.922.414.215.911.37.94.43.92.93.03.91.6
Current Liabilities58.257.562.829.836.224.222.616.021.07.96.74.74.55.72.1
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable3.54.84.78.010.76.79.34.17.911.8
Short-Term Debt32.532.933.736.034.737.346.45.35.49.8
Other Current Liabilities8.58.310.613.512.810.66.653.454.910.6
Current Liabilities44.545.949.157.558.254.662.462.868.232.2
Long-Term Liabilities TTM 20242023202220212020201920182017201620152014201320122011
Long-Term Debt143.3190.121.222.41.13.80.20.30.40.50.50.00.00.00.0
Capital Leases48.155.526.525.35.38.10.20.30.50.50.60.00.00.00.0
Def. Tax Liability0.00.00.00.00.00.81.71.81.20.70.40.00.00.00.0
Total Liabilities249.9247.8245.554.139.430.627.320.525.011.39.96.86.58.2158.1
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt176.9183.3187.5190.1191.4192.6173.621.222.323.1
Capital Leases58.158.757.555.550.647.025.526.527.728.0
Def. Tax Liability0.00.00.00.00.00.00.07.60.00.0
Total Liabilities221.8229.5236.8247.8249.9247.4236.6245.5257.457.1
Total Common Equity TTM 20242023202220212020201920182017201620152014201320122011
Common Stock0.20.20.20.20.20.20.20.20.20.20.20.20.20.00.1
Retained Earnings-294.2-323.0-207.0-73.248.6127.6163.7117.445.427.66.0-73.0-107.5-115.4-132.0
Comprehensive Income-0.70.3-1.2-3.7-0.40.80.1-0.4-0.10.00.0-0.10.00.00.0
Total Common Equity148.9128.8216.7321.3399.4455.6462.5393.7301.7269.9236.2148.7110.543.9-132.0
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.20.20.20.20.20.20.20.20.20.2
Retained Earnings-386.2-368.0-345.3-323.0-294.2-271.6-240.4-207.0-178.9-139.8
Comprehensive Income-0.4-0.20.00.3-0.7-0.7-0.5-1.2-1.5-1.8
Total Common Equity79.393.5111.8128.8148.9166.1191.9216.7237.8269.4
Other TTM 20242023202220212020201920182017201620152014201320122011
Total Debt226.2226.126.525.35.38.10.20.30.50.50.60.20.00.00.0
Book Value148.9128.8216.7321.3399.4455.6462.5393.7301.7269.9236.2148.7110.543.9-132.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value79.393.5111.8128.8148.9166.1191.9216.7237.8269.4
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income-115.3-81.9-116.0-133.8-121.8-79.0-36.246.472.017.721.779.034.49.621.423.37.9
Depreciation & Amortization2.55.12.32.43.03.33.63.32.52.11.70.60.40.20.20.50.6
Stock-Based Compensation25.818.626.828.227.021.019.619.215.813.19.45.82.71.10.40.20.3
Change Working Capital4.239.97.18.06.8-13.712.911.5-61.822.06.2-16.8-2.30.70.1-2.4-18.4
Change In Accounts Receivable10.031.81.09.43.3-0.127.815.9-56.62.22.4-13.6-0.90.2-0.8-0.30.0
Change In Accounts Payable-2.7-1.3-0.4-1.2-4.63.8-0.91.81.30.61.5-0.50.40.10.80.10.2
Change In Inventories-7.00.00.00.00.00.0-16.3-6.5-6.418.61.9-3.4-1.70.40.1-1.41.6
Other Non-cash Items10.7-0.91.02.60.2-2.0-3.5-5.8-1.2-0.6-0.7-3.00.2-1.80.52.7-0.5
Cash from Operations-90.00.00.0-103.2-84.8-70.07.171.429.252.735.876.720.210.722.624.0-10.2
Cash Flow From Operating Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Net Income-11.9-18.7-18.3-22.6-22.3-28.8-22.7-31.2-33.4-28.1
Depreciation & Amortization1.31.31.21.20.90.50.60.60.60.7
Stock-Based Compensation3.84.04.24.75.77.75.45.68.16.7
Change Working Capital-2.95.432.32.10.19.22.7-3.3-1.46.2
Change In Accounts Receivable-1.61.532.3-0.5-1.52.0-0.80.1-0.310.3
Change In Accounts Payable-0.1-0.7-1.30.9-0.2-1.50.9-4.95.2-3.8
Change In Inventories0.00.00.00.00.00.00.00.00.00.0
Other Non-cash Items-1.91.5-1.91.2-1.21.1-0.8-0.31.1-7.2
Cash from Operations0.00.00.00.00.00.00.00.00.0-21.6
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-10.4-12.9-17.9-9.1-2.1-0.8-1.4-5.4-3.0-2.5-4.7-2.3-1.0-0.6-0.3-0.40.0
Acquisitions-0.90.00.044.5-54.90.00.086.70.00.00.00.00.00.00.10.00.0
Investments-413.4-209.6-307.3-373.4-171.4-307.3-338.6-549.3-293.1-251.4-192.4-196.3-98.4-115.9-47.7-33.6-0.6
Sales of Investment474.8262.9383.5328.9228.5345.1359.8468.1260.7249.3153.5110.699.947.328.716.82.3
Other Investing Activities61.40.00.0-44.554.90.00.0-86.70.00.00.0-0.20.00.01.1-0.40.0
Cash from Investing51.00.00.0-53.654.937.019.8-86.7-35.4-4.6-43.7-88.20.5-69.2-18.0-17.71.7
Cash Flow From Investing Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Capital Expenditure-0.1-1.5-0.2-2.5-8.7-9.0-6.5-1.7-0.8-1.4
Acquisitions0.00.00.00.00.00.00.00.012.3-13.2
Investments-148.6-68.6-86.0-55.00.00.0-95.1-65.3-146.8-106.1
Sales of Investment101.572.459.753.277.628.095.3125.6134.5119.3
Other Investing Activities0.00.00.00.00.00.00.00.00.013.2
Cash from Investing0.00.00.00.00.00.00.00.00.011.8
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-7.20.00.00.00.00.00.0-0.1-0.1-0.1-0.10.00.00.00.0-2.00.0
Debt Issued205.6226.1199.51.319.9-2.87.90.0-0.10.00.00.40.20.00.02.00.0
Issuance of Common Stock-1.00.00.02.221.30.00.00.00.00.00.00.00.059.90.00.00.0
Repurchase of Common Stock-0.20.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities-13.30.00.0198.1-1.23.19.02.74.51.12.82.51.2-3.0-0.92.00.0
Cash from Financing-20.40.00.0198.120.03.19.02.64.41.02.72.51.256.9-0.90.00.0
Cash Flow From Financing Activities 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued0.0209.5-6.7-5.1-4.8-0.1-3.79.9193.5-1.2
Issuance of Common Stock0.00.00.00.00.00.00.00.00.0-1.1
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.00.00.0
Cash from Financing0.00.00.00.00.00.00.00.00.00.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-58.8-5.5-48.241.4-9.9-29.935.9-12.7-1.849.1-5.1-9.021.8-1.73.76.4-8.5
Closing Cash Balance36.435.741.289.448.057.887.751.863.965.716.621.730.78.910.56.80.5
Cash position 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Net Change in Cash5.1-12.5-15.4-24.747.11.5-27.823.6-45.5-9.8
Closing Cash Balance40.835.748.263.688.341.239.763.543.989.4
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow-100.3-32.2-96.7-112.2-86.9-70.75.666.026.250.131.174.319.210.022.423.6-10.2
Real Free Cash Flow-126.1-50.7-123.5-140.4-113.9-91.7-13.946.810.437.121.768.516.59.021.923.3-10.5
Free Cash Flow 1-20264-20253-20252-20251-20254-20243-20242-20241-20244-2023
Free Cash Flow-11.8-7.917.4-16.0-25.5-19.4-21.3-30.3-25.8-23.0
Real Free Cash Flow-15.7-12.013.2-20.7-31.2-27.1-26.7-35.8-33.9-29.7
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-3.713.5-1.4
P/S412.59.4
P/B3.43.15.2
P/FCF-7.610.4-1.5
Market cap$0.2$0.4
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %5.2 %0 %
Debt to Income-292.8 %-9.7 %0 %
Debt to Free cash flow-595.6 %4700.3 %0 %
Interest expense percentage-12 %1.8 %44.7 %
Current ratio5 15.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-90.2 %-9.7 %0 %
ROA-23.8 %-0.7 %0 %
CapEx to Revenue6.4 %6.3 %0 %
RaD to Revenue0 %111.4 %0 %
ROEM558,166.7 862140.5

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin100 %98 %68.7 %
Operating margin-109.1 %-62.8 %35.5 %
Net margin-106.8 %-59.2 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding21.4 mil 18.0 mil
Employee count0.1 tis 0.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader